20160128 EGA Regulatory and Scientific Affairs Conferenc

European Commission Question & Answer Document for Patients Builds Trust and Understanding on Biosimilar Medicines across Europe

25 October 2016

Today, the European Commission published a Q&A for patients on […]

Read more

EU countries urged to promote generics, biosimilars to meet rising costs of long-term care – report

18 October 2016

LONDON, Oct 18 (APM) – European countries should promote greater […]

Read more

NOR-SWITCH Study: Another Significant Example of Positive Real World Evidence on Physician-led Switching to Biosimilar Medicines

18 October 2016

Today at the United Gastro-Enterology (UEG) week in Vienna, the NOR-SWITCH […]

Read more

European Commission Strongly Recommends the Use of Generic and Biosimilar Medicines to Ensure the Sustainability of Healthcare Systems

14 October 2016

Medicines for Europe welcomes the publication of the ‘Joint Report […]

Read more

Generic medicines have enabled twice as many patients to get treatment for the same budget

12 October 2016

Presentation of the report “The Value of Generic Medicines” GENERIC […]

Read more

The Value Added Medicines Group Highlights the Importance of Access to Health during the CPhI Conference

3 October 2016

The Value Added Medicines Group a sector group of Medicines […]

Read more

Generic Medicines at the Heart of the French Public Health System

30 September 2016

Medicines for Europe strongly supports the French government campaign to […]

Read more

The global scourge of counterfeit medicines

29 September 2016


Generic Medicines save European Countries 100 Billion Euro per Year

28 September 2016

Lisbon, September 28, 2016 – Without the use of generic […]

Read more

Generic Medicines Increase Access to Treatments

27 September 2016


Subscribe to our newsletter